<DOC>
	<DOCNO>NCT00840762</DOCNO>
	<brief_summary>The investigator seek determine whether Virco®TYPE HIV-1 provide benefit equivalent provide local expert review . The investigator propose clinic patient Ruth M. Rothstein CORE Center genotypic test perform randomized 1:1 fashion local expert review Virco®TYPE HIV-1 . Results either method share primary HIV care provider . Patient outcomes review time point equal great 2 month 6 month follow change antiretroviral medication follow test</brief_summary>
	<brief_title>A Comparison Virco®TYPE HIV-1 Testing Versus Expert Interpretation Genotypic Results Control HIV-1 Replication</brief_title>
	<detailed_description>Patients document genotypic HIV resistance one fully active medication randomize either local review algorithmic review VircoType HIV-1 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIV resistance test demonstrates resistance least one drug Patients CORE Center , Chicago Illinois Wild type HIV resistance test less equal one active antiretroviral medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>HIV</keyword>
	<keyword>HIV Genotypic test</keyword>
	<keyword>resistance</keyword>
</DOC>